SCHEMBL6002908

SCHEMBL6002908

[CH2]CCOCCc1ccccc1Cl

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.48
HTR3E A5X5Y0 1/20 0.44
HTR3B O95264 1/20 0.44
HTR3A P46098 1/20 0.44
HTR3D Q70Z44 1/20 0.44
HTR3C Q8WXA8 1/20 0.44
IDO1 P14902 3/20 0.42
PNMT P11086 1/20 0.42
KCNH2 Q12809 2/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
AOC3 Q16853 1/20 0.42
HCAR2 Q8TDS4 1/20 0.40
DAO P14920 2/20 0.37
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28565719 0.90 TAAR1 (0.58) TAAR1HTR3EHTR3BHTR3AHTR3D
SCHEMBL27698431 0.89 TAAR1 (0.46) TAAR1HTR3EHTR3BHTR3AHTR3D
SCHEMBL6230376 0.82 IDO1 (0.53) TAAR1HTR3EHTR3BHTR3AHTR3D
SCHEMBL3171625 0.81 TAAR1 (0.48) TAAR1HTR3EHTR3BHTR3AHTR3D
SCHEMBL838926 0.79 TAAR1 (0.60) TAAR1HTR3EHTR3BHTR3AHTR3D
SCHEMBL2092714 0.78 TAAR1 (0.54) TAAR1HTR3EHTR3BHTR3AHTR3D
SCHEMBL2090266 0.77 TAAR1 (0.50) TAAR1IDO1AOC3HCAR2DAO
SCHEMBL900697 0.75 TAAR1 (0.56) TAAR1HTR3EHTR3BHTR3AHTR3D
SCHEMBL3583105 0.75 FFAR1 (0.48) TAAR1HTR3EHTR3BHTR3AHTR3D
SCHEMBL3113301 0.74 CYP1A2 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed